Mathew P. Thomas
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Hematology top 2%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
Papers in
-
- Systemic Lupus Erythematosus Research 6
- Genetics 4
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- William W. Freimuth (3 shared papers)Z. John Zhong (3 shared papers)Lilia Pineda (2 shared papers)A Gallacher (2 shared papers)Roger A. Levy (3 shared papers)Sandra Navarra (3 shared papers)Ho‐Youn Kim (1 shared paper)Eugeny L. Nasonov (1 shared paper)
- Journals
- Blood (3 papers)The Pediatric Infectious Disease Journal (2 papers)The Lancet (1 paper)Lara D. Veeken (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- United StatesIndiaPhilippines
In The Last Decade
Mathew P. Thomas
29 papers receiving 2.8k citations
Mathew P. Thomas's Hit Papers
Peers
Comparison fields: 5 of 96
- Rheumatology 1.6k
- Hematology 541
- Immunology 962
- Radiology, Nuclear Medicine and Imaging 644
- Genetics 211
Countries citing papers authored by Mathew P. Thomas
This map shows the geographic impact of Mathew P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew P. Thomas more than expected).
Fields of papers citing papers by Mathew P. Thomas
This network shows the impact of papers produced by Mathew P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew P. Thomas. The network helps show where Mathew P. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathew P. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2011 | 1618 |
| 2 | A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A Hit paper breakdown → | 2016 | 400 |
| 3 | Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus Hit paper breakdown → | 2012 | 347 |
| 4 | 2012 | 103 | |
| 5 | 2019 | 72 | |
| 6 | 2001 | 71 | |
| 7 | 2019 | 51 | |
| 8 | 1997 | 45 | |
| 9 | 2019 | 38 | |
| 10 | 2017 | 33 | |
| 11 | 2006 | 21 | |
| 12 | 2015 | 17 | |
| 13 | 2014 | 14 | |
| 14 | 2018 | 14 | |
| 15 | 2017 | 13 | |
| 16 | 1998 | 12 | |
| 17 | 2012 | 11 | |
| 18 | 2012 | 9 | |
| 19 | 2002 | 6 | |
| 20 | 2013 | 5 |
About Mathew P. Thomas
Mathew P. Thomas is a scholar working on Rheumatology, Genetics, Hematology, Epidemiology and Infectious Diseases, having authored 30 papers that have together received 2.9k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Hemophilia Treatment and Research (3 papers), Platelet Disorders and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmaceutical studies and practices (2 papers), Burn Injury Management and Outcomes (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Rheumatology (1.6k citations), Hematology (541 citations), Immunology (962 citations), Radiology, Nuclear Medicine and Imaging (644 citations) and Genetics (211 citations). Mathew P. Thomas has collaborated with scholars based in United States, India and Philippines. Frequent co-authors include William W. Freimuth, Z. John Zhong, Lilia Pineda, A Gallacher, Roger A. Levy, Sandra Navarra, Ho‐Youn Kim, Eugeny L. Nasonov, Michelle Petri and Stephen Hall. Their work appears in journals such as Blood, The Pediatric Infectious Disease Journal, The Lancet, Lara D. Veeken and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.